-
Sector Analysis
NewMethicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033
Methicillin-Resistant Staphylococcus aureus (MRSA) Report Overview In the 7MM, there were 714,131 hospitalized incident cases of Methicillin-Resistant Staphylococcus aureus (MRSA) in 2023. The hospitalized incident cases of Methicillin-Resistant Staphylococcus aureus (MRSA) will register an AGR of more than 1% during 2023-2033. Methicillin-resistant Staphylococcus aureus (MRSA) is a virulent, antibiotic-resistant bacteria that is associated with considerable morbidity and mortality. MRSA can be categorized according to the setting in which the infection was acquired, as either healthcare-associated MRSA (HA-MRSA), which is acquired...
-
Sector Analysis
Non-Small Cell Lung Cancer (NSCLC) Epidemiology Analysis and Forecast to 2032
Non-Small Cell Lung Cancer (NSCLC) Report Overview In the 8MM, there were 1,097,467 diagnosed incident cases of Non-Small Cell Lung Cancer (NSCLC) in 2022. The diagnosed incident cases of Non-Small Cell Lung Cancer (NSCLC) will register an AGR of more than 2% during 2022-2032. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, NSCLC can begin anywhere in the lungs when the healthy cells that make up the lining of the lungs change and grow out...
-
Sector Analysis
Ovarian Cancer Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Ovarian Cancer Market Report Overview The ovarian cancer market across the 7MM was valued at $3.3 billion in 2022. The market will grow at a CAGR of more than 1% from 2022 to 2032. The 7MM includes the US, France, Germany, Italy, Spain, the UK, and Japan. Ovarian cancer is one of the most lethal gynecological cancers worldwide. Approximately 90% of ovarian cancer cases are epithelial, with distinct sites of origin arising from the ovarian surface epithelium or distal fallopian...
-
Sector Analysis
Colorectal Cancer in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2031
Colorectal Cancer Market Report Overview The colorectal cancer market sales across the 8MM were estimated at $15.8 billion in 2021. The market is expected to achieve a CAGR of more than 3% during 2021-2031. The global growth is driven by the anticipated approval and launch of 14 pipeline therapies and the label expansions of other agents. Colorectal cancer Market Outlook, 2021-2031 ($ Billion) Buy the Full Report to Know More about the Colorectal cancer Market Forecast Download A Free Report...
-
Sector Analysis
Gout Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Gout Market Report Overview The Gout market across the 7MM (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan) was valued at $4.63 billion in 2022. Significant growth is expected at a CAGR of more than 8% from 2022 to 2032 as the gout population steadily increases and novel therapies enter the market. The US had the highest number of diagnosed prevalent cases of gout in 2022, followed by France and the UK. Gout is a form of...
-
Sector Analysis
Insomnia Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Insomnia Market Report Overview The Insomnia market across the 7MM (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan) was valued at $3.2 billion in 2022. Steady growth is anticipated at a CAGR of more than 2% from 2022 to 2032, due to the launch of four novel pipeline agents - Hetlioz, SM-1, vornorexant, and sunobinop. The insomnia market research report offers an overview of insomnia, including its epidemiology, symptoms, diagnosis, and disease management. The report offers key...
-
Sector Analysis
Major Depressive Disorder in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2029
Major Depressive Disorder Market Report Overview The major depressive disorder (MDD) market sales across the 8 major markets (MM) were valued at $4.73 billion in 2019. The market is expected to achieve a CAGR of more than 7% during 2019-2029. The US market makes up the most total global sales due to the large MDD prevalent population, combined with the high price of medication in the country. Major Depressive Disorder Market Outlook, 2019-2029 ($ Billion) Buy the Full Report to...
-
Sector Analysis
Female Contraceptives in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032
Female Contraceptives Market Report Overview The female contraceptives market sales across the 7MM was $7.8 billion in 2022. The market is expected to achieve a CAGR of less than 1% during 2022-2032. During the forecast period, sales of female contraceptives will increase in the UK due to the rising female population. Conversely, sales in France, Germany, Italy, and Spain markets will decrease owing to the declining female population. Female Contraceptives Market Outlook, 2022-2032 ($ Billion) Buy the Full Report to...